06.05.2024
Therapeutics
$3,778,831.00
36 months
Crohn's Fistulizing Program – Investigator Initiated Clinical Trials
This project aims to provide additional evidence for the safety and efficacy of MSC to enable larger scale clinical trials to support regulatory approval of MSC therapy for CD patients suffering with fistulae.